Le Lézard
Classified in: Health
Subjects: AWD, NPT

Dr. M.S. Ravindra receives inaugural Excellence in MSICS award from ISMSICS


CHENNAI, India, Dec. 3, 2017 /PRNewswire-USNewswire/ -- The International Society of Small Incision Cataract Surgeons (ISMSICS) has named Dr. M.S. Ravindra as the first recipient of the Dr. Jatin Shah award for Excellence in Manual Small Incision Cataract Surgery (MSICS).  The award was presented in a ceremony to Dr. Ravindra as part of the Comprehensive Cataract Conference 2017 (CCC 2017) in Chennai, India.

 (PRNewsfoto/HelpMeSee,ISMSICS)

The ISMSICS presented this award for Excellence in MSICS in memory of the late Dr. Jatin Shah (1954-2015), in recognition of his tireless efforts as an eye surgeon and in honor of his legacy training the next generation of cataract specialists.  Dr. Jatin Shah dedicated his life to restoring sight, working with numerous NGOs and philanthropic groups, most recently having served as HelpMeSee's Medical Officer for Asia.  He leaves a legacy as an expert of excellence in MSICS and advocacy to save sight.

Through his work over the last 35 years, Dr. M. S. Ravindra has become a leading ophthalmologist and medical researcher, developing innovative surgical techniques using the latest advanced technology.  As chairman and medical director of Karthik Netralaya specialty eye hospital, Dr. Ravindra's team has provided quality micro-surgical treatments serving countless people suffering from blindness and visual impairment.  He has trained many ophthalmologists in modern techniques, and has helped advocate training for affordable surgical treatment for cataracts across south Asia.

Dr. Amulya Sahu, chairman and co-founder of ISMSICS said, "We are honored to present an eye surgeon of Dr. Ravindra's caliber with the first Excellence in MSICS award.  Like the late Dr. Jatin Shah, he has dedicated his career to make safe, quality treatment available to even the neediest populations.  As a scientific advisor to ISMSICS, he has helped promote innovative treatment options for cataracts, and we thank him for his lifelong commitment to restoring sight."

Dr. Van Charles Lansingh, Chief Medical Officer at HelpMeSee said, "We congratulate Dr. Ravindra on this recognition, and thank him for his many contributions to advancing cataract treatment. HelpMeSee and ISMSICS are engaged to help promote MSICS as a safe, scalable, high-quality, cost-efficient procedure to reduce the burden of cataract blindness worldwide."

About ISMSICS
The International Society of Manual Small Incision Cataract Surgeons (ISMSICS) is an organization to promote excellence and accessibility in cataract surgery. The organization aims to improve outcomes of cataract surgery while providing better vision to patients at an affordable cost. The organization is surgeon focused and surgeon driven- of, for and by cataract surgeons. ISMSICS is dedicated to research and development in the field of cataract surgery, especially manual small incision cataract surgery, to make cataract surgery more accessible, affordable and give patients the best of vision.

About HelpMeSee
HelpMeSee is a non-profit organization committed to ending the global health crisis of cataract blindness. Through a focus on simulation-based training for cataract specialists, HelpMeSee has developed sustainable solutions to increase access to safe, affordable surgical treatment. HelpMeSee's goal is to improve quality and expand access to cataract care, including a network of thousands of trained cataract specialists across the developing world.

CONTACT: Matthew Hurst, (212) 221-7606 Ext. 127, [email protected]

 

SOURCE HelpMeSee; ISMSICS


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: